temozolomide has been researched along with tachyplesin peptide, tachypleus tridentatus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chugh, A; Jana, A; Kulshreshtha, R; Narula, P | 1 |
1 other study(ies) available for temozolomide and tachyplesin peptide, tachypleus tridentatus
| Article | Year |
|---|---|
Efficient delivery of anti-miR-210 using Tachyplesin, a cell penetrating peptide, for glioblastoma treatment.
Topics: Antagomirs; Antimicrobial Cationic Peptides; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell-Penetrating Peptides; DNA-Binding Proteins; Drug Carriers; Drug Compounding; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; MicroRNAs; Peptides, Cyclic; Reactive Oxygen Species; Signal Transduction; Temozolomide | 2019 |